Arturo Casadevall

Johns Hopkins University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Natural and human-made disasters can cause tremendous physical damage, societal change, and suffering. In addition to their effects on people, disasters have been shown to alter the microbial population in the area affected.

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Manuel J. Rodríguez-Ortega

Universidad de Córdoba

SPAIN

View details

Jonathon Senefeld

Assistant Professor

University of Illinois at Urbana-Champaign

UNITED STATES

View details

Fabrizio Maggi

Associate Professor

University Hospital of Pisa

ITALY

View details

Vitor Laerte Pinto Junior

Professor auxiliar convidado

Universidade do Porto Faculdade de Medicina

PORTUGAL

View details

Joshua D Nosanchuk

Albert Einstein College of Medicine

UNITED STATES

View details

Marc Johnson

Professor

University of Missouri School of Medicine

UNITED STATES

View details

david sullivan

Johns Hopkins University Bloomberg School of Public Health

UNITED STATES

View details

Ruth E Stark

Distinguished Professor

CUNY City College of New York

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Arturo Casadevall

Research Interests

Explore related searches

Contact this professor

Articles (15)

Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis

Avoided and Avoidable Deaths with the Use of COVID-19 Convalescent Plasma in Italy during the First Two Years of Pandemic

Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients

Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants

Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge

WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?

Faster <i>Cryptococcus</i> Melanization Increases Virulence in Experimental and Human Cryptococcosis

Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence

Melanization of Candida auris Is Associated with Alteration of Extracellular pH

Disaster Microbiology—a New Field of Study

On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID19 Prophylaxis and Treatment

Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review

Extracellular Vesicles from Different Pneumococcal Serotypes Are Internalized by Macrophages and Induce Host Immune Responses

COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors

Collaborators (8)

Manuel J. Rodríguez-Ortega

Jonathon Senefeld

Fabrizio Maggi

Vitor Laerte Pinto Junior

Joshua D Nosanchuk

Marc Johnson

david sullivan

Ruth E Stark

Make your next move.